Moreover, future studies should analyze FOXJ1 expression and other markers of MCC differentiation in a large series of breast carcinomas, including all molecular subtypes, to better understand the biological and clinical significance of this specific type of cellular differentiation. This evidence concerns the gene FOXJ1 and breast carcinoma.